NUBIA LOMELI: Open Payments
NPI 1619328374 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,265 in 49 payments from 17 companies in 2025. Trend: 2023 $1,030 · 2024 $1,292 · 2025 $1,265
Food & beverage: $1,265
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $385 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $144 |
| Amgen Inc. | 5 | $141 |
| Lilly USA, LLC | 6 | $99 |
| Novo Nordisk Inc | 4 | $83 |
| Abbott Laboratories | 2 | $70 |
| ABBVIE INC. | 3 | $67 |
| Edwards Lifesciences Corporation | 1 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $35 |
Products named: AIRSUPRA, Kerendia, OTEZLA, MOUNJARO, REXULTI, Ozempic, SAPIEN 3 Ultra RESILIA, AVEIR.
Industry payments across AZ — which companies pay providers there.
